Wilsey Asset Management Inc Gilead Sciences, Inc. Transaction History

Wilsey Asset Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$62.63 - $80.22 $9.64 Million - $12.4 Million	-153,980 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$61.62 - $67.78 $281,911 - $310,093	4,575 Added 3.06%	153,980 $9.96 Million
Q3 2019 Oct 15, 2019	BUY	$62.51 - $69.0 $754,995 - $833,382	12,078 Added 8.8%	149,405 $9.5 Million
Q2 2019 Aug 26, 2019	BUY	$61.87 - $69.38 $212,275 - $238,042	3,431 Added 2.56%	137,327 $9.3 Million
Q1 2019 Apr 09, 2019	BUY	$62.53 - $70.05 $422,265 - $473,047	6,753 Added 5.31%	133,896 $8.74 Million
Q4 2018 Feb 01, 2019	BUY	$60.54 - $79.0 $366,267 - $477,950	6,050 Added 5.0%	127,143 $7.88 Million
Q3 2018 Oct 09, 2018	SELL	$71.28 - $78.92 $161,164 - $178,438	-2,261 Reduced 1.83%	121,093 $9.41 Million
Q2 2018 Aug 22, 2018	SELL	$64.88 - $75.68 $1,751 - $2,043	-27 Reduced 0.02%	123,354 $8.72 Million
Q1 2018 Apr 18, 2018	BUY	$72.84 - $88.8 $93,890 - $114,463	1,289 Added 1.06%	123,381 $9.23 Million
Q4 2017 Feb 05, 2018	BUY	$71.15 - $83.52 $419,002 - $491,849	5,889 Added 5.07%	122,092 $8.75 Million
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $8.38 Million - $9.93 Million	116,203	116,203 $9.61 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Wilsey Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Wilsey Asset Management Inc with notifications on news.